Voyager Therapeutics
Price & Volume
Stats
See more52W Range | $2.83-$5.55 |
Market Cap | $220.5M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $36.4M |
Revenue Growth (YoY) | -59.9% |
Gross Profit (12 Mos) | -$88.8M |
Diluted EPS | -$1.98 |
News
See moreYahoo Finance • 8 days ago
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
Yahoo Finance • 30 days ago
What Voyager Therapeutics Inc (VYGR) Has Gained on Its Therapy Programs
Yahoo Finance • 7 months ago
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
Yahoo Finance • 7 months ago
Voyager Reports Third Quarter 2025 Financial and Operating Results
About
CEO | Dr. Alfred W. Sandrock Jr., M.D., Ph.D. |
Address | 75 Hayden Avenue, Lexington, MA, United States, 02421 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 141 |